These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28110649)

  • 1. Mass Spectrometry Imaging in Oncology Drug Discovery.
    Goodwin RJ; Bunch J; McGinnity DF
    Adv Cancer Res; 2017; 134():133-171. PubMed ID: 28110649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Histology and Pathology in Mass Spectrometry Imaging.
    Schwamborn K
    Adv Cancer Res; 2017; 134():1-26. PubMed ID: 28110647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mass spectrometry: challenges in visualization of drug distribution in solid tumors.
    Morosi L; Zucchetti M; D'Incalci M; Davoli E
    Curr Opin Pharmacol; 2013 Oct; 13(5):807-12. PubMed ID: 23810822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance.
    Jove M; Spencer J; Clench M; Loadman PM; Twelves C
    Crit Rev Oncol Hematol; 2019 Sep; 141():153-162. PubMed ID: 31302407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry Imaging in Cancer Research: Future Perspectives.
    McDonnell LA; Angel PM; Lou S; Drake RR
    Adv Cancer Res; 2017; 134():283-290. PubMed ID: 28110655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical and Concise Review of Mass Spectrometry Applied to Imaging in Drug Discovery.
    Goodwin RJA; Takats Z; Bunch J
    SLAS Discov; 2020 Oct; 25(9):963-976. PubMed ID: 32713279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
    Balluff B; Hanselmann M; Heeren RM
    Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
    Buck A; Aichler M; Huber K; Walch A
    Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambient Mass Spectrometry in Cancer Research.
    Takats Z; Strittmatter N; McKenzie JS
    Adv Cancer Res; 2017; 134():231-256. PubMed ID: 28110652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues.
    Porta Siegel T; Hamm G; Bunch J; Cappell J; Fletcher JS; Schwamborn K
    Mol Imaging Biol; 2018 Dec; 20(6):888-901. PubMed ID: 30167993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research.
    Lee RFS; Theiner S; Meibom A; Koellensperger G; Keppler BK; Dyson PJ
    Metallomics; 2017 Apr; 9(4):365-381. PubMed ID: 28154861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Potential of Metal-Assisted Imaging Mass Spectrometry in Cancer Research.
    Dufresne M; Patterson NH; Lauzon N; Chaurand P
    Adv Cancer Res; 2017; 134():67-84. PubMed ID: 28110656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage.
    Huang KT; Ludy S; Calligaris D; Dunn IF; Laws E; Santagata S; Agar NY
    Adv Cancer Res; 2017; 134():257-282. PubMed ID: 28110653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer and comparative imaging.
    LeBlanc AK
    ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Digital Image Recognition Methods for Mass Spectrometry Imaging Data Analysis.
    Ekelöf M; Garrard KP; Judd R; Rosen EP; Xie DY; Kashuba ADM; Muddiman DC
    J Am Soc Mass Spectrom; 2018 Dec; 29(12):2467-2470. PubMed ID: 30324263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging in oncology drug development.
    Mudd SR; Comley RA; Bergstrom M; Holen KD; Luo Y; Carme S; Fox GB; Martarello L; Beaver JD
    Drug Discov Today; 2017 Jan; 22(1):140-147. PubMed ID: 27693713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Mass Spectrometry Imaging to Cancer.
    Arentz G; Mittal P; Zhang C; Ho YY; Briggs M; Winderbaum L; Hoffmann MK; Hoffmann P
    Adv Cancer Res; 2017; 134():27-66. PubMed ID: 28110654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
    Swales JG; Tucker JW; Strittmatter N; Nilsson A; Cobice D; Clench MR; Mackay CL; Andren PE; Takáts Z; Webborn PJ; Goodwin RJ
    Anal Chem; 2014 Aug; 86(16):8473-80. PubMed ID: 25084360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future technology insight: mass spectrometry imaging as a tool in drug research and development.
    Cobice DF; Goodwin RJ; Andren PE; Nilsson A; Mackay CL; Andrew R
    Br J Pharmacol; 2015 Jul; 172(13):3266-83. PubMed ID: 25766375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery.
    Grondin A; Pillon A; Vandenberghe I; Guilbaud N; Kruczynski A; Gomes B
    Bioanalysis; 2016 Jul; 8(14):1481-98. PubMed ID: 27314564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.